NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Atherosclerosis



Research on atherosclerosis detailed by scientists at Showa Pharmaceutical University



September 16th, 2008

"PPAR gamma regulates the expression of numerous genes. In addition to their anti-diabetic activity, PPAR gamma agonists have been reported to have beneficial effects for cancer, inflammation including inflammatory bowel disease, atherosclerosis and brain inflammation, as well as bone turnover," investigators in Tokyo, Japan report.

"To investigate a potential new class of ligands for PPAR gamma, we designed with reference to the crystal structure of the ligand-binding domain of PPAR gamma oxidized docosahexaenoic acid (DHA) derivatives, which have a hydrophilic substituent at the C(4)-position and are putative metabolites of DHA. We synthesized 14 compounds and...


Source: Cancer Weekly (2008-09-16)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login